NEWARK, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the following healthcare conferences during the month of May.

Bank of America Merrill Lynch 2016 Health Care Conference
Date: Tuesday, May 10, 2016
Time: 8:40 a.m. PDT
Location: Las Vegas, Nevada

2016 UBS Global Healthcare Conference
Date: Monday, May 23, 2016
Time: 9:00 a.m. EDT
Location: New York, New York

These presentations will be webcast and can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcasts will be archived for 30 days.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit www.depomed.com. 

Investor Contact:

Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000
ckeenan@depomed.com

Primary Logo